Latest Research Reports

Report: Clostridium difficile infections market to reach $1.7bn by 2026

The global clostridium difficile infections (CDIs) market is expected to witness a compound annual growth rate (CAGR) of 10.2%, increasing from $630m in 2016 to $1.7bn by 2026, according to...

Report: Clostridium difficile infections market to reach $1.7bn by 2026

Early detection of invasive breast cancer substandard in urban China

Early detection of invasive breast cancer substandard in urban China

Anti-diabetic treatments with non-glycemic benefits: driver of growth

Anti-diabetic treatments with non-glycemic benefits: driver of growth

Report: Canadian pharmaceuticals market to witness a nominal CAGR of 2% up to 2021

The Canadian pharmaceutical market is projected to witness a compound annual growth rate (CAGR) of 2%, growing from $22.6bn in 2016 to $25bn by 2021, according to a report by...

Report: Canadian pharmaceuticals market to witness a nominal CAGR of 2% up to 2021

US faces high, growing burden of CDI

US faces high, growing burden of CDI

Despite challenges, pain-related indications are most frequently researched clinical trials

Despite challenges, pain-related indications are most frequently researched clinical trials

Healthcare-related CDIs rivaled by community cases

Healthcare-related CDIs rivaled by community cases

Declining trend in Japanese clinical trials

Declining trend in Japanese clinical trials

Will Orencia be able to compete in an already crowded market?

Will Orencia be able to compete in an already crowded market?

Report: Heart failure market set to reach $16bn by 2026

The heart failure market is expected to witness a compound annual growth rate of 15.7%, from $3.7bn in 2016 to $16.1bn by 2026, according to a report by...

Report: Heart failure market set to reach $16bn by 2026

Non-industry trials were more frequent than industry trials in 2016

Non-industry trials were more frequent than industry trials in 2016

Chlamydia testing, one step back but two steps forward

Chlamydia testing, one step back but two steps forward

Report: Polish pharmaceutical industry set to reach $11bn by 2021

The Polish pharmaceutical industry is projected to record a steady compound annual growth rate of 3.2%, according to a report by...

Report: Polish pharmaceutical industry set to reach $11bn by 2021

Analyst forecasted growth of battling blockbusters, Keytruda and Opdivo

Analyst forecasted growth of battling blockbusters, Keytruda and Opdivo

AML therapeutics market expected to diversify by 2026

AML therapeutics market expected to diversify by 2026

Which class of drugs is set to have the biggest impact on the cancer market?

Which class of drugs is set to have the biggest impact on the cancer market?

Monoclonal antibodies make up seven out of the top ten investigated drugs in 2016

Monoclonal antibodies make up seven out of the top ten investigated drugs in 2016

Report: Singapore’s pharmaceutical market to reach $1.2bn by 2020

The pharmaceutical market in Singapore is expected to cross the $1bn mark by 2021, growing at a compound annual growth rate of 5%, according to a report by...

Report: Singapore’s pharmaceutical market to reach $1.2bn by 2020

Glioblastoma: could Zika virus offer new treatment options?

Glioblastoma: could Zika virus offer new treatment options?

Diagnosed incident cases of cystic fibrosis are set to decrease

Diagnosed incident cases of cystic fibrosis are set to decrease

China and infectious disease: the one to watch?

China and infectious disease: the one to watch?